期刊文献+

彩色多普勒超声评估乳腺癌新辅助化疗疗效的应用价值 被引量:8

Color Doppler Ultrasound in the Evaluation of Curative Effect of Neoadjuvant Chemotherapy for Breast Cancer
下载PDF
导出
摘要 目的研究彩色多普勒超声在对新辅助化疗治疗乳腺癌后疗效评估中的价值。方法对65例乳腺癌患者总共70个肿块使用超声引导,经过粗针穿刺活检后确诊为浸润性乳腺癌后,经过临床评估符合使用新辅助化疗的标准者进行新辅助化疗治疗,在采用化疗前1周以及化疗后手术前进行彩色多普勒超声检查,对血流分布、血流阻力指数以及肿瘤大小进行分析,根据治疗效果将患者分为有效组(CR组+PR组)和无效组(SD组+PD组),对术后的病理结果进行对比分析。结果 CR组有7例。在PR组中,采用新辅助化疗治疗前后病灶的RI值及血流变化均表现出显著相关性(P<0.01),治疗前后病灶的PSV不存在明显的差异;无效组化疗前后病灶内的RI值以及PSV值均无明显相关性。结论使用彩色多普勒超声对乳腺癌的血流参数以及病灶大小检测,具有客观评价的效果,具有良好的临床意义。 Objective To study the value of color doppler ultrasound in the evaluation of curative effect of neoadjuvant chemotherapy for breast cancer. Methods 65 cases of patients with a total of 70 tumors received ultrasound guidance, confirmed after coarse needle biopsy to be invasive breast cancer ,through the clinical evaluation standard with the new adjuvant chemothera- py for neoadjuvant chemotherapy treatment, 1 week before chemotherapy and after chemotherapy, preoperative color doppler ultra- sound examination was conducted, blood flow distribution, blood flow resistance index and tumor size were analyzed, and according to curative effect, the patients were divided into valid group( CR + PR) and invalid group(SD + PD group) ,postoperative path- ological results were analyzed. Results CR group has 7 cases. In PR group before and after neoadjuvant chemotherapy, RI values and blood flow changes of lesions showed significant correlation( P 〈 0.01 ) , before and after treatment, PSV of lesions had no ob- vious difference;In invalid group before and after chemotherapy, RI value and PSV had no significant correlation. Conclusion Color doppler flow imaging in the detection of blood flow parameters and lesion size of breast cancer has objective effect and good clinical significance.
出处 《实用癌症杂志》 2016年第9期1459-1461,1465,共4页 The Practical Journal of Cancer
关键词 超声检查 彩色 多普勒 乳腺癌 Ultrasonic examination Color Doppler Breast cancer
  • 相关文献

参考文献11

二级参考文献56

  • 1侯新燕,简文豪,矫健,黄其敏,彭雁,焦冰.高频彩色多普勒超声在乳腺癌钼靶X线摄影阴性诊断中的应用价值[J].中华医学超声杂志(电子版),2007,4(3):162-164. 被引量:17
  • 2任洪波,王琦,李少林,黄碧有.术前化疗结合放疗治疗炎性乳腺癌疗效分析[J].中国肿瘤临床,2006,33(7):384-385. 被引量:7
  • 3蔡海峰,赵刚,潘惠承.新辅助化疗在隐匿性乳腺癌中的应用[J].中国综合临床,2006,22(6):538-539. 被引量:4
  • 4Von MG, Costa SD, Eiermonn W, et al. Maximized reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and Docetaxel[J]. J Clin Oncol, 1999, 17 (7): 1999- 2005.
  • 5Kuhl CK, Mideareck P, Klaschik S, et al. Dynamic breast MR ima ging : are signal intensity time course data useful for differential di agnosis of enhancing lesions [ J ]. Radiology, 19 9 9,211 ( 1 ) : 101- 110.
  • 6Ogston KN, Miller ID,Payne S, etal. A new histological grading systemto assess response of breast cancers to primary chemother- apy: prognostic significance and survival[J]. Breast, 2003,12 ( 5 ) : 320-327.
  • 7Bonadonna G, Valagussa P, Brambilla C, et al. Primary chemother- apy in operable breast cancer: eight-year experience at the milan cancer institute[J].J Clin Oncol, 1998,16 (1) : 93-100.
  • 8Toj M. Tumor angiogenesis in breast cancer, its importance as a prognostic indicator and the association with vascular endothelial growth factor expression[J]. Breast Cancer Res Treat, 1995,36 (2):193.
  • 9Rieber A,Brambs H J, Gabelmann A, et al. Breast MRI for moni toring response of primary breast cancer to neo adjuvant chemo- therapy[J]. Eur Radiol,2002,12(7) : 1711- 1719.
  • 10Schimmin R, Hunter NR, Mason KA, et al. Inhibition of tumor neo-angiogenesis and induction of apoptosis as properties of do- cetaxel (taxotere) [J]. Mund Kiefer Gesichtschir, 1999, 3 ( 4 ) : 210-212.

共引文献435

同被引文献72

引证文献8

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部